Antibodies in Repeated Influenza Vaccination (ARIVA) Study
Condition: Vaccine Response Impaired Intervention: Biological: Influenza Vaccination Sponsors: University Hospital, Basel, Switzerland; University of Oslo; University of Oxford; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Influenza | Influenza Vaccine | Research | Study | Switzerland Health | Vaccines